用户名: 密码: 验证码:
The α7-nicotinic Acetylcholine Receptors Mediate the Imidacloprid-Induced Inhibition of Mast Cell Degranulation Through Syk Signaling Pathway
详细信息    查看官网全文
摘要
Backgroud: Imidacloprid has been commonly used as an insecticide for crop protection worldwide and act as nicotinic acetylcholine receptors(nAChRs) agonists. It was shown that nAChRs are involved in the pathology of allergic disease. Among the nicotinic receptors, α7 is the most commonly found nAChR subunit on immune cells.Our previous studies showed that 10-3-10-11 mol /L imidacloprid can inhibit Ig E-mediated mast cell degranulation. However, the underlying mechanism for it remains unclear.Objective: This study aims to further explore the underlying mechanisms by which imidacoprid inhibits the Ig E-meditated mast cell degranulation.Methods:In this study, the Ig E-sensitized rat mast cell/basophil cell line(RBL-2H3) was incubated with methyllycaconitine(MLA),the antagonist of a7-nAChRs, prior to the treatment of imidacloprid, finaly the cells were stimulated with DNP-HAS. Then the allergic mediator production and influx of Ca2+ in Ig E-activated RBL-2H3 and the expression of phosphorylation antibodies in Syk mast cell signaling was measured;Meanwhile, the vascular extravasation in Ig E-induced passive cutaneous anaphylaxis(PCA) of the Balb/c mice ear was investigated.Results:The results showed,compared to the only imidacloprid treatment groups, the groups incubated with MLA, prior to the treatment of imidacloprid have higher amount of histamine, β-hexosaminidase(β-hex), LTC4, IL-6,TNF-α production and Ca2+ influx from Ig E-activated RBL-2H3 and higher phosphorylation content of signaling molecules such as Lyn, Sky, Fyn, ERK, p38, JNK,PLC-γ and NF-κB in mast cell Syk signaling.Furthermore,MLA can also alleviate the inhibition of imidacloprid on Ig E-activated PCA which was induced by mast cell degraunlation.Conclusions:It is the first time to show that the α7-nAChRs mediate the imidacloprid-induced inhibition of mast cell degranulation through Syk signaling pathway.This study suggests that the agonist of α7-nAChR might be a potential therapeutic strategy to control allergic diseases.
Backgroud: Imidacloprid has been commonly used as an insecticide for crop protection worldwide and act as nicotinic acetylcholine receptors(nAChRs) agonists. It was shown that nAChRs are involved in the pathology of allergic disease. Among the nicotinic receptors, α7 is the most commonly found nAChR subunit on immune cells.Our previous studies showed that 10-3-10-11 mol /L imidacloprid can inhibit Ig E-mediated mast cell degranulation. However, the underlying mechanism for it remains unclear.Objective: This study aims to further explore the underlying mechanisms by which imidacoprid inhibits the Ig E-meditated mast cell degranulation.Methods:In this study, the Ig E-sensitized rat mast cell/basophil cell line(RBL-2H3) was incubated with methyllycaconitine(MLA),the antagonist of a7-nAChRs, prior to the treatment of imidacloprid, finaly the cells were stimulated with DNP-HAS. Then the allergic mediator production and influx of Ca2+ in Ig E-activated RBL-2H3 and the expression of phosphorylation antibodies in Syk mast cell signaling was measured;Meanwhile, the vascular extravasation in Ig E-induced passive cutaneous anaphylaxis(PCA) of the Balb/c mice ear was investigated.Results:The results showed,compared to the only imidacloprid treatment groups, the groups incubated with MLA, prior to the treatment of imidacloprid have higher amount of histamine, β-hexosaminidase(β-hex), LTC4, IL-6,TNF-α production and Ca2+ influx from Ig E-activated RBL-2H3 and higher phosphorylation content of signaling molecules such as Lyn, Sky, Fyn, ERK, p38, JNK,PLC-γ and NF-κB in mast cell Syk signaling.Furthermore,MLA can also alleviate the inhibition of imidacloprid on Ig E-activated PCA which was induced by mast cell degraunlation.Conclusions:It is the first time to show that the α7-nAChRs mediate the imidacloprid-induced inhibition of mast cell degranulation through Syk signaling pathway.This study suggests that the agonist of α7-nAChR might be a potential therapeutic strategy to control allergic diseases.
引文

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700